Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; core content and data remain unchanged.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a detailed list of publications related to a specific clinical trial. Notably, the drug sargramostim has been both added and removed, indicating a potential revision in its relevance or context within the content.SummaryDifference6%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.